Fernando Aleman (Fernando Alemán)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Mass Spectrometry

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

Pain management

Navega Therapeutics

Universidad de Murcia - Campus de Espinardo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Navega Therapeutics

United States

Co-founder, president and CSO

Inova Diagnostics

United States

Consultant

Scripps Research Institute

United States

Research Associate

University of California San Diego

United States

Postdoctoral Fellow :: Division of Biological Sciences

Education History

Universidad de Murcia - Campus de Espinardo

Spain

PHD :: CEBAS-CSIC

Publications

Ana M Moreno, Fernando Aleman, Glaucilene F Catroli, Matthew A Hunt, Michael Hu, Amir Dailamy, Andrew Pla, Sarah A Woller, Nathan D Palmer, Udit Parekh, Daniella McDonald, Amanda J Roberts, Vanessa Goodwill, Ian Dryden, Robert F Hevner, Lauriane Delay, Gilson Gonçalves Dos Santos, Tony L Yaksh, Prashant Mali
Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice. Science translational medicine 13 (584) (2021)
Andrea Vega-Loza, Christina Van, Ana M Moreno, Fernando Aleman
Gene therapies to reduce chronic pain: are we there yet? Pain management 10 (4) (2020)
Fernando Aleman, Netanel Tzarum, Leopold Kong, Kenna Nagy, Jiang Zhu, Ian A Wilson, Mansun Law
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors. Proceedings of the National Academy of Sciences of the United States of America 115 (29) (2018)